Abiraterone Acetate
Abiraterone Acetate is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Abiraterone Acetate; Generic name: ABIRATERONE ACETATE; Manufacturer: Dr. Reddys Laboratories Inc.
| Brand name | Abiraterone Acetate |
|---|---|
| Generic name | ABIRATERONE ACETATE |
| Manufacturer | Dr. Reddys Laboratories Inc |
| Used for | 1 INDICATIONS AND USAGE Abiraterone acetate tablets are indicated in combination with prednisone for the treatment of patients with Metastatic castration-resistant prostate cancer (CRPC) Metastatic high-risk castration-sensitive prostate cancer (CSPC) Abiraterone acetate tablet is a CYP17 inhibitor indicated in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer (CRPC). ( 1) metastatic high-risk castration-sensitive prostate cancer (CSPC). ( 1 ) |
| Dosage | 2 DOSAGE AND ADMINISTRATION Metastatic castration-resistant prostate cancer: • Abiraterone acetate tablets 1,000 mg orally once daily with prednisone 5 mg orally twice daily. ( 2.1 ) Metastatic castration-sensitive prostate cancer: • Abiraterone acetate tablets 1,000 mg orally once daily with prednisone 5 mg orally once daily. ( 2.2 ) Patients receiving abiraterone acetate tablets should also receive a gonadotropin-releasing hormone (GnRH) analog concurrently or should have had bilateral orchi |
| Active ingredient(s) | ABIRATERONE ACETATE |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0c91aa38-3b0a-232c-8eb1-55f08e8e6644 |